HHS: 'No Surprises Act Drug Pricing Report to Congress'
December 13, 2024
December 13, 2024
WASHINGTON, Dec. 13 (TNSres) -- The U.S. Department of Health and Human Services issued the following report on December 4, 2024, by the ASPE Office of Health Policy entitled "No Surprises Act Drug Pricing Report to Congress."
Here are excerpts:
* * *
Prescription drug prices are a top concern for policymakers and the public, but little data is available on prescription drug prices or other costs that contribute to premiums for commercial drug cov . . .
Here are excerpts:
* * *
Prescription drug prices are a top concern for policymakers and the public, but little data is available on prescription drug prices or other costs that contribute to premiums for commercial drug cov . . .